COMMUNIQUÉS West-GlobeNewswire

Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
27/07/2026
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Mont-Saint-Guibert, Belgium – July 27, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), [...]
Nyxoah Publiera ses Résultats Financiers du Deuxième Trimestre 2026 le 5 août 2026
27/07/2026
Nyxoah Publiera ses Résultats Financiers du Deuxième Trimestre 2026 le 5 août 2026 Mont-Saint-Guibert, Belgique – 27 juillet 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « [...]
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
27/07/2026
BRANFORD, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule [...]
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, August 10, 2026, at 4:30 p.m. Eastern Time to report [...]
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
27/07/2026
CANTON, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports [...]
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
27/07/2026
ALAMEDA, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed [...]
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
27/07/2026
Conference Call to Begin Today at 4:30 p.m. ET MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for [...]
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
27/07/2026
Dr. Rooney, former immunology leader at Johnson & Johnson, will lead clinical development strategy across Kymera’s industry-leading oral immunology portfolio Jared Gollob, MD, will retire from his role after eight [...]
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
27/07/2026
SOUTH SAN FRANCISCO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the second quarter ended June 30, [...]
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
27/07/2026
CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
27/07/2026
RADNOR, Pa., July 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease
27/07/2026
Cambridge, Massachusetts, July 27, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded [...]
Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
27/07/2026
July 27, 2026 Q2 2026 Group performance Comparable order intake declined 1%, due to timing of certain large orders Group sales of EUR 4.4 billion, reflecting 4% comparable sales growth Income from operations of EUR 609 [...]
ORYZON Reports Financial Results and Corporate Update for Half Year Ended June 30th, 2026
27/07/2026
Positive clinical data presented at EHA for iadademstat in first line acute myeloid leukemia (AML); iadademstat+azacitidine+venetoclax resulted in 100% ORR, 89% CRc and 78% CR, including in patients with TP53 or RAS [...]
Elevar Therapeutics Announces Three Abstracts Accepted for Presentation at ESMO Congress 2026
27/07/2026
FORT LEE, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and [...]
Atalante X, Wandercraft’s Self-Balancing Rehabilitation Exoskeleton, Receives ARCSA Clearance in Ecuador, Advancing Latin American Expansion
27/07/2026
Clearance broadens access to hands-free, overground robotic gait training in Ecuador, and supports Wandercraft’s plans to expand advanced rehabilitation technology across Latin America NEW YORK and QUITO, Ecuador, July [...]
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
27/07/2026
Digital subscription platform brings together the Company’s proprietary consumer health products across consumer (B2C) and corporate (B2B) channels Customers can begin through one of three paths: a free nutritionist [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2026
27/07/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 20th July to 24th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 30 - 2026
27/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 20 juillet au 24 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]

Pages